medication. The magnitude of the decline in performance from the immediate to the delayed paradigm was linked to the size of the hippocampi at time of testing. One year later, the prolonged febrile seizure group still showed impairments in remembering a face after a 5 min delay. Age at the time of the seizure was not a factor. COMMENT. In this study concerning the effects of prolonged febrile seizures on recognition memory, a visual paired comparison task employing faces was used to test memory abilities in small infants. Prosopagnosia, an inability to recognize faces, is congenital and genetic or acquired. The congenital form may be inherited by ~2.5% of the population. The brain region associated with prosopagnosia is usually stated as the fusiform gyrus or an occipito-temporal location, contiguous with the hippocampal gyrus, the location emphasized in the above study. Congenital prosopagnosia is not rare. Oliver Sacks himself confused the faces of his brothers and learned that his relatives were similarly affected ( 
ATYPICAL FACE SHAPE AND GENOMIC VARIANTS IN EPILEPSY
Researchers at the Institute of Neurology, Queen Square, London; Children's Hospital, Florence, Italy; and other centers in the UK, Belgium, and the Netherlands studied face shape abnormalities in 118 children and adults attending three European epilepsy clinics, using an objective measure called Face Shape Difference to show that those with pathogenic structural variants have a significantly atypical face shape. In a second group of 63 patients the predictive accuracy of the measure showed high sensitivity (80% for whole face, 60% for periorbital and perinasal regions) and specificity (78% for whole face and perinasal regions, 69% for periorbital region). Computer-based stereophotogrammetry and dense surface models were effective in detecting subtle relevant face shape abnormalities or dysmorphisms in patients with epilepsy and pathogenic structural genomic variants, as determined by chromosome microarray. COMMENT. Patients with epilepsy and pathogenic structural genomic microarray variants have an objectively more atypical face shape compared with those without. The authors suggest that an evaluation for facial dysmorphism should be part of the clinical work-up for epilepsy. The concept of a "facies epileptica" as defined by Turner (Turner WA. Epilepsy: A Study of the Idiopathic Disease. London: Macmillan and Co; 1907.) , is now regarded as unacceptable. Given the heterogeneity of epilepsy, 3D stereophotogrammetry and dense surface models are not expected to identify a specific "face" associated with epilepsy, and actual facial shapes are as varied as the underlying pathogenic structural variants. An objective measure of face shape variation might be used in clinical selection of patients with epilepsy who should be considered for microarray chromosome analysis.
GENETIC NEUROLOGICAL SYNDROMES EPILEPSY IN MUENKE SYNDROME
Researchers at the National Institutes of Health, Bethesda, MD; Children's National Medical Center; and George Washington University, Washington, DC present 7 patients with Muenke syndrome complicated by epilepsy. A review of 789 published cases of Muenke syndrome with neurological complications identified epilepsy in 6 cases, with intracranial anomalies in 5. The intracranial anomalies were agenesis of the corpus callosum, hemimegalencephaly, and porencephaly. COMMENT. Muenke syndrome has an autosomal dominant inheritance and is characterized by craniosynostosis, most commonly coronal uni-or bilateral, asymmetry of skull and face, sensorineural hearing loss, developmental delay, broad toes and thumbs, fusion of carpal and tarsal bones, hypertelorism, ptosis, strabismus, midface hypoplasia, and fronto-temporal bossing. The syndrome is caused by a mutation in the 
